科研之友
微信
新浪微博
Facebook
分享链接
摘要
Utilizing genomic signatures from diagnostic tumor samples to forecast clinical behavior and response to therapy has long been a goal, and we are now poised to further refine how we can identify the relatively rare patients with aggressive neuroblastoma masquerading as patients with a more benign form of the disease.
- 出版日期2015-4-15
